Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome (Q92286651)
Jump to navigation
Jump to search
scientific article published on 17 June 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome |
scientific article published on 17 June 2019 |
Statements
Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome (English)
M Holmqvist
L Westermark
A Björk
M Kvarnström
S Magnusson Bucher
P Eriksson
E Theander